AMENDED AND RESTATED FOUNDERS AGREEMENTFounders Agreement • January 12th, 2017 • Avenue Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 12th, 2017 Company Industry JurisdictionTHIS AMENDED AND RESTATED FOUNDERS AGREEMENT (this “Agreement”) is made as of September 13, 2016 (the “Effective Date”) by and between Fortress Biotech, Inc., a Delaware corporation (the “Founder”), and Avenue Therapeutics, Inc., a Delaware corporation (the “Company”).
AMENDED AND RESTATED FOUNDERS AGREEMENTFounders Agreement • July 11th, 2016 • Checkpoint Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 11th, 2016 Company Industry JurisdictionTHIS AMENDED AND RESTATED FOUNDERS AGREEMENT (this “Agreement”) entered into on July 11, 2016, shall be effective as of March 17, 2015 (the “Effective Date”) by and between Fortress Biotech, Inc., a Delaware corporation (the “Founder”), and Checkpoint Therapeutics, Inc. (the “Company”).
FOUNDERS AGREEMENTFounders Agreement • March 24th, 2016 • Checkpoint Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 24th, 2016 Company Industry JurisdictionTHIS FOUNDERS AGREEMENT (this “Agreement”) is entered into as of March 17, 2015 (the “Effective Date”) by and between Fortress Biotech, Inc., a Delaware corporation (the “Founder”), and Checkpoint Therapeutics, Inc. (the “Company”).
FOUNDERS AGREEMENTFounders Agreement • December 30th, 2015 • Avenue Therapeutics, Inc. • New York
Contract Type FiledDecember 30th, 2015 Company JurisdictionTHIS FOUNDERS AGREEMENT (this “Agreement”) is effective as of February 17, 2015 (the “Effective Date”) by and between Fortress Biotech, Inc., a Delaware corporation (the “Founder”), and Avenue Therapeutics, Inc. (the “Company”).